Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis
Many studies have reported the risk factors for exacerbations in patients with 2019 novel coronavirus (2019-nCoV). This study aims to perform the meta-analysis of risk factors for the exacerbation of the novel coronavirus-infected pneumonia (NCIP). PubMed, Embase and Google scholar have been searche...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378653/ https://www.ncbi.nlm.nih.gov/pubmed/32714077 http://dx.doi.org/10.7150/ijms.47052 |
_version_ | 1783562467653189632 |
---|---|
author | Zhao, Jinqiu Li, Xiaosong Gao, Yao Huang, Wenxiang |
author_facet | Zhao, Jinqiu Li, Xiaosong Gao, Yao Huang, Wenxiang |
author_sort | Zhao, Jinqiu |
collection | PubMed |
description | Many studies have reported the risk factors for exacerbations in patients with 2019 novel coronavirus (2019-nCoV). This study aims to perform the meta-analysis of risk factors for the exacerbation of the novel coronavirus-infected pneumonia (NCIP). PubMed, Embase and Google scholar have been searched. We included the cohort studies involving risk factors for the exacerbation of NCIP. This meta-analysis compared the risk factors of patients between intensive care (ICU) group and non-ICU group. Two cohort studies were included in this study. After comparing the patients between intensive care (ICU) group and non-ICU group, several important factors were found to significantly increase the risk of exacerbations in patients with NCIP, and they included hypertension (RR=2.34; 95% CI=1.21 to 4.51; P=0.01), cardiovascular diseases (RR=2.28; 95% CI=1.13 to 4.58; P=0.02), COPD (RR=7.65; 95% CI=1.24 to 47.13; P=0.03), dyspnea (RR=2.89; 95% CI=2.05 to 4.08; P<0.00001), myalgia or fatigue (RR=1.24; 95% CI=1.01 to 1.52; P=0.04), but several factors such as gender, Huanan Seafood Wholesale Market exposure, diabetes, chronic liver disease, malignancy, fever, cough, expectoration, headache and diarrhoea appeared to have no obvious effect on the exacerbation of pneumonia. In addition, as the exacerbation of pneumonia, some complications had the high probability to occur according to the meta-analysis of acute respiratory distress syndrome (ARDS) (RR=13.95; 95% CI=6.20 to 31.41; P<0.00001), shock (RR=24.29; 95% CI=4.66 to 126.69; P=0.0002), acute cardiac injury (RR=10.32; 95% CI=3.05 to 34.96; P=0.0002) and acute kidney injury (RR=5.90; 95% CI=1.32 to 26.35; P=0.02) between two groups. Several risk factors were confirmed to significantly improve the risk of exacerbation in patients with NCIP, which was very important for the exacerbation prediction and treatment of these patients. |
format | Online Article Text |
id | pubmed-7378653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-73786532020-07-24 Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis Zhao, Jinqiu Li, Xiaosong Gao, Yao Huang, Wenxiang Int J Med Sci Research Paper Many studies have reported the risk factors for exacerbations in patients with 2019 novel coronavirus (2019-nCoV). This study aims to perform the meta-analysis of risk factors for the exacerbation of the novel coronavirus-infected pneumonia (NCIP). PubMed, Embase and Google scholar have been searched. We included the cohort studies involving risk factors for the exacerbation of NCIP. This meta-analysis compared the risk factors of patients between intensive care (ICU) group and non-ICU group. Two cohort studies were included in this study. After comparing the patients between intensive care (ICU) group and non-ICU group, several important factors were found to significantly increase the risk of exacerbations in patients with NCIP, and they included hypertension (RR=2.34; 95% CI=1.21 to 4.51; P=0.01), cardiovascular diseases (RR=2.28; 95% CI=1.13 to 4.58; P=0.02), COPD (RR=7.65; 95% CI=1.24 to 47.13; P=0.03), dyspnea (RR=2.89; 95% CI=2.05 to 4.08; P<0.00001), myalgia or fatigue (RR=1.24; 95% CI=1.01 to 1.52; P=0.04), but several factors such as gender, Huanan Seafood Wholesale Market exposure, diabetes, chronic liver disease, malignancy, fever, cough, expectoration, headache and diarrhoea appeared to have no obvious effect on the exacerbation of pneumonia. In addition, as the exacerbation of pneumonia, some complications had the high probability to occur according to the meta-analysis of acute respiratory distress syndrome (ARDS) (RR=13.95; 95% CI=6.20 to 31.41; P<0.00001), shock (RR=24.29; 95% CI=4.66 to 126.69; P=0.0002), acute cardiac injury (RR=10.32; 95% CI=3.05 to 34.96; P=0.0002) and acute kidney injury (RR=5.90; 95% CI=1.32 to 26.35; P=0.02) between two groups. Several risk factors were confirmed to significantly improve the risk of exacerbation in patients with NCIP, which was very important for the exacerbation prediction and treatment of these patients. Ivyspring International Publisher 2020-07-06 /pmc/articles/PMC7378653/ /pubmed/32714077 http://dx.doi.org/10.7150/ijms.47052 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Zhao, Jinqiu Li, Xiaosong Gao, Yao Huang, Wenxiang Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis |
title | Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis |
title_full | Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis |
title_fullStr | Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis |
title_full_unstemmed | Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis |
title_short | Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis |
title_sort | risk factors for the exacerbation of patients with 2019 novel coronavirus: a meta-analysis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378653/ https://www.ncbi.nlm.nih.gov/pubmed/32714077 http://dx.doi.org/10.7150/ijms.47052 |
work_keys_str_mv | AT zhaojinqiu riskfactorsfortheexacerbationofpatientswith2019novelcoronavirusametaanalysis AT lixiaosong riskfactorsfortheexacerbationofpatientswith2019novelcoronavirusametaanalysis AT gaoyao riskfactorsfortheexacerbationofpatientswith2019novelcoronavirusametaanalysis AT huangwenxiang riskfactorsfortheexacerbationofpatientswith2019novelcoronavirusametaanalysis |